Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.9 USD | +4.39% | +10.39% | +41.33% |
Feb. 16 | Philips' Medical Imaging Machines Recall Termed 'Most Serious' by US FDA | MT |
Feb. 15 | US FDA classifies Philips' recall of imaging machines as 'most serious' | RE |
Financials (USD)
Sales 2024 * | 2.84B | Sales 2025 * | 2.92B | Capitalization | 1.12B |
---|---|---|---|---|---|
Net income 2024 * | 51M | Net income 2025 * | 87M | EV / Sales 2024 * | 0.67 x |
Net Debt 2024 * | 771M | Net Debt 2025 * | 718M | EV / Sales 2025 * | 0.63 x |
P/E ratio 2024 * |
52.7
x | P/E ratio 2025 * |
25.9
x | Employees | 20,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.68% |
Latest transcript on BrightView Holdings, Inc.
1 day | +4.39% | ||
1 week | +10.39% | ||
Current month | +36.62% | ||
1 month | +38.21% | ||
3 months | +39.18% | ||
6 months | +55.15% | ||
Current year | +41.33% |
Managers | Title | Age | Since |
---|---|---|---|
Dale Asplund
CEO | Chief Executive Officer | 56 | 23-09-30 |
Brett Urban
DFI | Director of Finance/CFO | 41 | 15-12-31 |
Brian Bruce
CTO | Chief Tech/Sci/R&D Officer | - | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Abrahamson
BRD | Director/Board Member | 68 | 15-07-31 |
Mara Swan
BRD | Director/Board Member | 64 | 19-04-14 |
Kurtis T. Barker
BRD | Director/Board Member | 63 | 23-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 8 M€ | +9.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 11.9 | +4.39% | 1,286,350 |
24-03-27 | 11.4 | +1.15% | 433,950 |
24-03-26 | 11.27 | -2.00% | 824,481 |
24-03-25 | 11.5 | +0.61% | 1,131,353 |
24-03-22 | 11.43 | +2.33% | 672,623 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.33% | 1.08B | |
+14.00% | 69.55B | |
+18.44% | 19.22B | |
+13.87% | 14.03B | |
+23.66% | 13.84B | |
0.00% | 12.95B | |
+1.98% | 10.25B | |
+17.40% | 10.12B | |
-31.78% | 5.96B | |
-5.07% | 5.92B |